10 July 2024
10 July 2024
Accu-Chek SmartGuide offers critical predictions for diabetes management.
The new technology works in conjunction with the KardiaMobile 6L device and KardiaStation app.
The test reported a sensitivity of 97% for CRC and 88% for advanced precancerous lesions, with a specificity of 93%.
The preclinical trial alongside the US Department of Defense saw success with Cresilon gearing up for an FDA approval.
The Fitbone Transport and Lengthening System is designed to address large bone defects in the femur and tibia.
Users of the Kaia app in the Rise-uP study saw a 46% reduction in lower back pain intensity at 12 months compared to the control group.
The data from the Phase III study showed the efficacy of Swing’s smartphone-based behavioural therapy, Stanza, in improving fibromyalgia symptoms.
The MERLIN_001 Study involved nine centres across the US and has enrolled 1,640 patients over the past three years.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
